Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer
Authors
Keywords
Gastric cancer, Kinesin II-associated protein, TIMP metallopeptidase inhibitor 1, Stanniocalcin 2
Journal
World Journal of Surgical Oncology
Volume 11, Issue 1, Pages 81
Publisher
Springer Nature
Online
2013-04-02
DOI
10.1186/1477-7819-11-81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of SPARC Protein Expression in the Progress of Gastric Cancer
- (2012) Lifeng Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
- (2011) Vilde D Haakensen et al. BMC CANCER
- BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy
- (2011) Alessandra Bommarito et al. ENDOCRINE-RELATED CANCER
- Circulating microRNAs in plasma of patients with gastric cancers
- (2010) M Tsujiura et al. BRITISH JOURNAL OF CANCER
- Stanniocalcin-2 promotes epithelial–mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
- (2010) Alice Y.S. Law et al. EXPERIMENTAL CELL RESEARCH
- High-Level Expression of S100A4 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer
- (2009) Yuan-Yu Wang et al. ANNALS OF SURGICAL ONCOLOGY
- KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
- (2009) Takeshi Yokoe et al. ANNALS OF SURGICAL ONCOLOGY
- SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients
- (2009) Z.-S. Zhao et al. CLINICAL CANCER RESEARCH
- Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
- (2009) Alice Y.S. Law et al. EXPERIMENTAL CELL RESEARCH
- The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers
- (2009) Natalie Jeffery et al. HISTOPATHOLOGY
- Clinicopathological significance ofstanniocalcin 2gene expression in colorectal cancer
- (2009) Keisuke Ieta et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of Stanniocalcin 2 as Prognostic Marker in Renal Cell Carcinoma
- (2008) Hellmuth-A. Meyer et al. EUROPEAN UROLOGY
- SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion
- (2008) Kaoru Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma
- (2008) Yuichiro YOSHINO et al. JOURNAL OF DERMATOLOGY
- Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
- (2008) Sanda Raulic et al. JOURNAL OF ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started